The estimated Net Worth of Robert W Fairbairn is at least $2.67 million dollars as of 22 November 2021. Mr. Fairbairn owns over 53,141 units of BlackRock Science and Technology Term Trust stock worth over $97,960 and over the last 7 years he sold BSTZ stock worth over $2,573,142. In addition, he makes $0 as Trustee at BlackRock Science and Technology Term Trust.
Sign up
Mr. Fairbairn BSTZ stock SEC Form 4 insiders trading
Robert has made over 6 trades of the BlackRock Science and Technology Term Trust stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 53,141 units of BSTZ stock worth $1,046,878 on 22 November 2021.
The largest trade he's ever made was selling 53,141 units of BlackRock Science and Technology Term Trust stock on 22 November 2021 worth over $1,046,878. On average, Robert trades about 19,542 units every 220 days since 2017. As of 22 November 2021 he still owns at least 5,278 units of BlackRock Science and Technology Term Trust stock.
You can see the complete history of Mr. Fairbairn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Fairbairn biography
Robert W. Fairbairn serves as Trustee of the Company.He has more than 25 years of experience with BlackRock, Inc. and over 30 years of experience in finance and asset management. In particular, Mr. Fairbairn’s positions as Vice Chairman of BlackRock, Inc., Member of BlackRock’s Global Executive and Global Operating Committees and Co-Chair of BlackRock’s Human Capital Committee provide the Boards with a wealth of practical business knowledge and leadership. In addition, Mr. Fairbairn has global investment management and oversight experience through his former positions as Global Head of BlackRock’s Retail and iShares® businesses, Head of BlackRock’s Global Client Group, Chairman of BlackRock’s international businesses and his previous oversight over BlackRock’s Strategic Partner Program and Strategic Product Management Group. Mr. Fairbairn also serves as a board member for the funds in the BlackRock Multi-Asset Complex.
How old is Robert Fairbairn?
Robert Fairbairn is 55, he's been the Trustee of BlackRock Science and Technology Term Trust since 2018. There are 9 older and 5 younger executives at BlackRock Science and Technology Term Trust. The oldest executive at BlackRock Science and Technology Term Trust is Richard Cavanagh, 74, who is the Independent Co-Chairman of the Board of Trustees.
Insiders trading at BlackRock Science and Technology Term Trust
Over the last 5 years, insiders at BlackRock Science and Technology Term Trust have traded over $378,009 worth of BlackRock Science and Technology Term Trust stock and bought 160,232 units worth $3,828,683 . The most active insiders traders include Tony Kim, Karen P Robards et Kyle Mc Clements. On average, BlackRock Science and Technology Term Trust executives and independent directors trade stock every 48 days with the average trade being worth of $105,439. The most recent stock trade was executed by Kyle Mc Clements on 31 January 2024, trading 753 units of BSTZ stock currently worth $13,976.
What does BlackRock Science and Technology Term Trust do?
blackrock's business is investing on behalf of our clients, from large institutions to parents and grandparents, doctors and teachers who entrust their savings to us. we work only for our clients—period. our promise is to offer them the clearest thinking about what to do with their money and the products and services they need to secure a better financial future. that's why investors of all kinds have made us the world’s largest asset manager, entrusting us with trillions of dollars, and it’s why companies, institutions and global governments come to us for help meeting their biggest financial challenges. important disclosures: http://www.blackrock.com/corporate/en-us/compliance/social-media-guidelines
What does BlackRock Science and Technology Term Trust's logo look like?
Complete history of Mr. Fairbairn stock trades at Blackrock, BlackRock Health Sciences Term Trust, BlackRock Science and Technology Term Trust et BlackRock Capital Allocation Trust
BlackRock Science and Technology Term Trust executives and stock owners
BlackRock Science and Technology Term Trust executives and other stock owners filed with the SEC include:
-
Catherine Lynch,
Independent Trustee -
W. Carl Kester,
Independent Trustee -
R. Glenn Hubbard,
Independent Trustee -
Robert Fairbairn,
Trustee -
Frank Fabozzi,
Independent Trustee -
Cynthia Egan,
Independent Trustee -
Michael Castellano,
Independent Trustee -
Janey Ahn,
Secretary -
Jay Fife,
Treasurer -
Jonathan Diorio,
Vice President -
Charles Park,
Chief Compliance Officer -
Neal Andrews,
Chief Financial Officer -
John Perlowski,
President, Chief Executive Officer, Trustee -
Richard Cavanagh,
Independent Co-Chairman of the Board of Trustees -
Karen Robards,
Independent Co-Chairman of the Board of Trustees -
Christopher Accettella,
-
Tony Kim,
-
Kyle Mc Clements,
-
Steven Reid Menge,